BMC Infectious Diseases (Nov 2020)
Correction to: The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
Abstract
An amendment to this paper has been published and can be accessed via the original article.